The invention provides compounds of Formula I or a pharmaceutically acceptable salt or ester thereof wherein the symbols have meaning as defined, which are inhibitors of cathepsin K and find use pharmaceutically for treatment of diseases and medical conditions in which cathepsin K is implicated, e.g. various disorders including inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors.
本发明提供了公式I的化合物,或其药理学上可接受的盐或
酯,其中符号具有定义的含义,这些化合物是卡
特普西林K的
抑制剂,并在药学上用于治疗与卡
特普西林K有关的疾病和医疗条件,例如各种疾病,包括炎症,类风湿性关节炎,骨关节炎,骨质疏松和肿瘤。